Company Filing History:
Years Active: 2017
Title: Max Endele: Innovator in Recombinant Parvovirus Production
Introduction
Max Endele is a notable inventor based in Wilhelmsfeld, Germany. He has made significant contributions to the field of virology, particularly in the production of recombinant parvoviruses. His innovative work has implications for various applications in medical research and biotechnology.
Latest Patents
Max Endele holds a patent for an "Adenovirus derived helper virus for enhancing recombinant parvovirus production." This patent describes an adenovirus derived helper virus that may comprise the adenoviral DNA sequences for E2a, S4 (orf6), the VA1 RNA gene, and the parvovirus VP capsid gene unit. The patent also outlines a method for efficiently preparing a recombinant parvovirus particle, utilizing various adenoviral derived helper viruses and vectors. He has 1 patent to his name.
Career Highlights
Max Endele is associated with the Deutsches Krebsforschungszentrum, a leading cancer research center in Germany. His work at this institution has allowed him to explore innovative solutions in the field of virology and contribute to advancements in cancer research.
Collaborations
Max Endele has collaborated with notable colleagues, including Nazim El-Andaloussi and Antonio Marchini. These collaborations have further enriched his research and contributed to the development of new methodologies in recombinant virus production.
Conclusion
Max Endele's contributions to the field of recombinant parvovirus production highlight his innovative spirit and dedication to advancing medical research. His work continues to inspire future developments in virology and biotechnology.